[1. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global Cardiac Remodeling After Acute Myocardial Infarction: A Study in the Rat Model. J Am Coll Cardiol. 1985;5(6):1355-1362.10.1016/S0735-1097(85)80348-X]Search in Google Scholar
[2. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.008]Search in Google Scholar
[3. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978;41(7):1127-1132.10.1016/0002-9149(78)90869-X]Search in Google Scholar
[4. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30(2):73-110.10.1016/0033-0620(87)90004-1]Search in Google Scholar
[5. Sutton MG, Sharpe N. Left Ventricular Remodeling After Myocardial Infarction — Pathophysiology and Therapy. Circulation. 2000;101(25):2981-2988.10.1161/01.CIR.101.25.2981]Search in Google Scholar
[6. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of Initial Infarct Size to Extent of Left Ventricular Remodeling in the Year After Acute Myocardial Infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-O]Search in Google Scholar
[7. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979;300(2):57-62.10.1056/NEJM197901113000202]Search in Google Scholar
[8. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol. 1982;49(5):1120-1126.10.1016/0002-9149(82)90035-2]Search in Google Scholar
[9. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74(4):693-702.10.1161/01.CIR.74.4.6933757183]Search in Google Scholar
[10. Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarct expansion. Circulation. 1991;84(5):2123-2134.10.1161/01.CIR.84.5.21231934383]Search in Google Scholar
[11. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-O]Search in Google Scholar
[12. van Gilst WH, Kingma JH, Peels KH, Dambrink JH, St John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 1996;28(1):114-121.10.1016/0735-1097(96)00113-1]Search in Google Scholar
[13. Dujardin KS, Enriquez-Sarano M, Rossi A, Bailey KR, Seward JB. Echocardiographic Assessment of Left Ventricular Remodeling: Are Left Ventricular Diameters Suitable Tools? J Am Coll Cardiol. 1997;30(6):1534-1541.10.1016/S0735-1097(97)00329-X]Search in Google Scholar
[14. Gottdiener JS, Livengood SV, Meyer PA, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25(2):424-430.10.1016/0735-1097(94)00375-Z]Search in Google Scholar
[15. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.00821232712]Search in Google Scholar
[16. Marwick T. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. 2003;89(Suppl3):iii2–iii8.10.1136/heart.89.suppl_3.iii2187630014594869]Search in Google Scholar
[17. Mosca L, Barrett-Connor E, Kass Wenger N. Sex/Gender Differences in Cardiovascular Disease Prevention, What a Difference a Decade Makes. Circulation. 2011;124(19):2145–2154.10.1161/CIRCULATIONAHA.110.968792336205022064958]Search in Google Scholar
[18. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-Related Differences in Myocardial Remodeling. J Am Coll Cardiol. 2010;55(11):1057-1065.10.1016/j.jacc.2009.09.06520223363]Search in Google Scholar
[19. Ednei LA, Andrey JS, dos Santos AA, et al. Are there gender differences in left ventricular remodeling after myocardial infarction in rats? Rev Bras Cir Cardiovasc. 2015;30(1):70–76.]Search in Google Scholar
[20. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91(3):173-183.10.1159/00000690610516411]Search in Google Scholar
[21. Konstam MA, Udelson JE, Anand IS, Cohn JN. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail. 2003;9(5):350-353.10.1054/j.cardfail.2003.09.00114583894]Search in Google Scholar
[22. Zornoff LAM, Matsubara BB, Matsubara LS, et al. Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction. Arq Bras Cardiol. 2006;86(4):276-282]Search in Google Scholar
[23. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225-236.10.1097/00000441-200104000-0000311307864]Search in Google Scholar
[24. Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982;66(1):55-60.10.1161/01.CIR.66.1.557083520]Search in Google Scholar
[25. Messerli FH. Cardiomyopathy of obesity: a not-so-Victorian disease. N Engl J Med. 1986;314:378-38010.1056/NEJM1986020631406082935738]Search in Google Scholar
[26. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006;98(1):116-2010.1016/j.amjcard.2006.01.06316784933]Search in Google Scholar
[27. Litwin SE. Cardiac Remodeling in Obesity Time for a New Paradigm. JACC Cardiovasc Imaging. 2010;3(3):275-7.10.1016/j.jcmg.2009.12.00420223424]Search in Google Scholar
[28. Avelar E, Cloward TV, Walker JM. Left Ventricular Hypertrophy in Severe Obesity Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass. Hypertension. 2007;49(1):34-9.10.1161/01.HYP.0000251711.92482.1417130310]Search in Google Scholar
[29. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.10.1093/eurheartj/ehm18417556348]Search in Google Scholar
[30. Park D-W, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-2027.10.1001/jama.2014.1509525399277]Search in Google Scholar
[31. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57(1):84-95.10.1161/01.RES.57.1.843891127]Search in Google Scholar
[32. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319(2):80-86.10.1056/NEJM1988071431902042967917]Search in Google Scholar
[33. Sweet CS, Emmert SE, Stabilito II, Ribeiro LG. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987;10(6):636-642.10.1097/00005344-198712000-00005]Search in Google Scholar
[34. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial cfft’cts of loneterm therapy with captopril. Circulation. 1985;72(2):406-412.10.1161/01.CIR.72.2.406]Search in Google Scholar
[35. Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol. 1992;19(3):713-721.10.1016/S0735-1097(10)80298-0]Search in Google Scholar
[36. Pfeffer MA1, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.10.1161/01.CIR.81.4.1161]Search in Google Scholar
[37. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a topographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 1989;13(7):1506-1513.10.1016/0735-1097(89)90340-9]Search in Google Scholar
[38. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994;343(8906):1115-1122.]Search in Google Scholar
[39. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345(8951):669-685.10.1016/S0140-6736(95)90865-X]Search in Google Scholar